Ren Shen Yangrong Tang for Fatigue in Cancer Survivors: A Phase I/Ii Open-Label Study

Journal of Alternative and Complementary Medicine - United States
doi 10.1089/acm.2014.0211
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

A Combined Phase I and II Open Label Study on the Effects of a Seaweed Extract Nutrient Complex on Osteoarthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2010English

Growth Effects of Methylphenidate Among Childhood Cancer Survivors: A 12-Month Case-Matched Open-Label Study

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Blood Making Effect of Ninjin-Yoei-To(Ren-Shen-Yang-Rong-Tang) as Monotherapy in Obstetric and Gynecologic Patients With Anemia.

Kampo Medicine
1999English

A Phase I Open Label Study of the Farnesyltransferase Inhibitor CP-609,754 in Patients With Advanced Malignant Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Multi-Institutional, Phase II Open-Label Study of Ganitumab (AMG 479) in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2013English

OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Phase I Open Label Liver-Directed Gene Therapy Clinical Trial for Acute Intermittent Porphyria

Journal of Hepatology
Hepatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy